Partial List of Products Bearing the Same Neutral Code associated with QP Pharmachem
Photos of products containing the same neutral code as QP Pharmachem.
Photos of products containing the same neutral code as QP Pharmachem.
The examination of IndiaMART’s verification processes reveals significant issues with transparency and safety in the pharmaceutical sector. Notably, QP Pharmachem, a manufacturer of anabolic steroids and previously flagged for producing contaminated medications, remains a verified supplier. Companies like Matrix Biolabs and Evolve Biolabs claim WHO-GMP and ISO certifications without providing verifiable evidence. The neutral code system, crucial for tracking manufacturing origins, links these companies to QP Pharmachem, raising concerns about product quality and regulatory compliance. This article highlights the importance of thorough verification and regulatory oversight to protect consumers and maintain the integrity of the pharmaceutical industry.
The rise of underground labs (UGLs) in the U.S. presents significant risks for consumers of pharmaceuticals like Clomiphene, Tamoxifen, Tadalafil, and Sildenafil. Many UGLs source raw materials from China, where quality control is often lacking, leading to potential contamination with harmful substances such as heavy metals. Furthermore, UGLs typically lack proper equipment for accurate dosing, increasing health risks for users. Consumers are urged to seek medications from legal, trusted sources that adhere to stringent regulatory standards, ensuring safety and efficacy. This article delves into the dangers of UGLs and highlights safer alternatives.
IndiaMART, a major online marketplace, is under scrutiny for its role in the sale of pharmaceuticals. The platform’s lack of stringent verification processes and focus on bulk sales have led to the distribution of tainted medications, raising significant global health concerns. Incidents involving suppliers like QP Pharmachem highlight the dangers of unregulated pharmaceutical sales, including the risk of contamination with harmful substances. This article delves into the implications for global healthcare, the erosion of trust in legitimate Indian pharmacies, and the influence of regulatory bodies like LegitScript, emphasizing the need for stricter oversight and consumer awareness.
Americans seeking affordable healthcare solutions often turn to generic pharmaceuticals from countries like India. However, they face significant barriers in using common payment methods such as Visa, MasterCard, PayPal, and Venmo to purchase these medications. This article explores how shadow regulation, particularly by LegitScript, influences payment processors to block transactions related to online pharmacies, and how Big Pharma and government collusion perpetuate these obstacles. The narrative portrays online generic pharmacies as fraudulent, while in reality, this is a form of commercial protectionism benefitting a select few. By recognizing these challenges and advocating for transparency, consumers can better navigate the complex landscape of pharmaceutical access.